Display options
Cite
Papa V, Costantino A, Belfiore A. Insulin receptor what role in breast cancer?. Trends Endocrinol Metab. 1997;8(8):306-12doi: 10.1016/s1043-2760(97)00114-8.
Papa, V., Costantino, A., & Belfiore, A. (1997). Insulin receptor what role in breast cancer?. Trends in endocrinology and metabolism: TEM, 8(8), 306-12. https://doi.org/10.1016/s1043-2760(97)00114-8
Papa, V, et al. "Insulin receptor what role in breast cancer?." Trends in endocrinology and metabolism: TEM vol. 8,8 (1997): 306-12. doi: https://doi.org/10.1016/s1043-2760(97)00114-8
Papa V, Costantino A, Belfiore A. Insulin receptor what role in breast cancer?. Trends Endocrinol Metab. 1997 Oct;8(8):306-12. doi: 10.1016/s1043-2760(97)00114-8. PMID: 18406819.
Copy Download .nbib Format: NLM
Share it on

Trends Endocrinol Metab. 1997 Oct;8(8):306-12. doi: 10.1016/s1043-2760(97)00114-8.

Insulin receptor what role in breast cancer?.

Trends in endocrinology and metabolism: TEM

V Papa, A Costantino, A Belfiore

Affiliations

  1. Medical Department, SIFI SpA, Lavinaio (Catania), 95020, Italy.

PMID: 18406819 DOI: 10.1016/s1043-2760(97)00114-8

Abstract

It is commonly believed that the insulin receptor mainly mediates the metabolic effects of insulin, whereas the closely related IGF-I receptor is considered a major factor for the regulation of cell proliferation. Experimental and epidemiological evidence indicates, however, that insulin and insulin receptors may play an important role in breast cancer. This article reviews evidence indicating that (a) insulin receptors are overexpressed in human breast cancer, (b) insulin stimulates growth in breast cancer cells, (c) cells transfected with human insulin receptor may acquire a ligand-dependent transformed phenotype, and (d) breast cancer is associated with insulin resistance and hyperinsulinemia. These findings may open new possibilities in breast cancer prevention, prognosis assessment, and therapy. (Trends Endocrinol Metab 1997; 8:306-312). (c) 1997, Elsevier Science Inc.

Publication Types